Similar articles

• Autoradiographic detection of substance P receptors in normal and psoriatic skin.

  Pincelli C, Fantini F, Giardino L, Zanni M, Calzá L, Sevignani C, Giannetti A. Pincelli C, et al. J Invest Dermatol. 1993 Sep;101(3):301-4. doi: 10.1111/1523-1747.ep12365423. J Invest Dermatol. 1993. PMID: 7690377
• The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

  Lamberts SW, Krenning EP, Reubi JC. Lamberts SW, et al. Endocr Rev. 1991 Nov;12(4):450-82. doi: 10.1210/edrv-12-4-450. Endocr Rev. 1991. PMID: 1684746 Review. No abstract available.
• Somatostatin immunoreactive cells in lesional psoriatic human skin during peptide T treatment.

  Johansson O, Hilliges M, Talme T, Marcusson JA, Wetterberg L. Johansson O, et al. Acta Derm Venereol. 1994 Mar;74(2):106-9. doi: 10.2340/0001555574106109. Acta Derm Venereol. 1994. PMID: 7911613
• Somatostatin receptors as markers for endocrine tumors.

  Reubi JC. Reubi JC. JAMA. 1987 Jun 19;257(23):3277. JAMA. 1987. PMID: 2884334 No abstract available.
• Somatostatin receptors in malignant tissues.

  Reubi JC, Krenning E, Lamberts SW, Kvols L. Reubi JC, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1073-7. doi: 10.1016/0960-0760(90)90468-z. J Steroid Biochem Mol Biol. 1990. PMID: 1981010 Review.